TNBC is defined as tumors lacking hormone receptors (estrogen and progesterone) and HER2 expression and represents approximately 15–20% of all breast cancer patients and is associated with a poor prognosis [23]. This evidence concerns the gene ERBB2 and breast carcinoma.